PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathy

Back

EHRA Premium Access

PKP2 gene therapy reduces ventricular arrhythmias, reverses ventricular remodeling, improves heart function, and reduces mortality in a mouse model of arrhythmogenic right ventricular cardiomyopathy

Session: Basic science 1

Topic: Cardiac Diseases

Speaker: Doctor J. Yang (South San Francisco, US)

Event: EHRA 2024

Congress Presentation

About the speaker

Doctor Jane Yang

Tenaya Therapeutics, South San Francisco (United States of America)

0 follower

8 more presentations in this session

Right ventricular pacing-evoked left ventricular dysfunction is exaggerated by sustained left ventricular pressure overload in a rat model

Speaker: Doctor M. Ruppert (Budapest, HU)

Bioenergetics and mitochondrial deregulation underlie self-sustained persistency of atrial fibrillation in an ovine model

Speaker: Doctor G. Caluori (Bordeaux, FR)

Senolysis ameliorates increased susceptibility to ventricular arrhythmias in prediabetes

Speaker: Doctor S. Angendohr (Duesseldorf, DE)

The entrainment of action potential duration and contraction amplitude by recapitulation of respiratory sinus arrhythmia in isolated cardiac myocytes

Speaker: Doctor A. Carpenter (Bristol, GB)

Circadian rhythm in pro-arrhythmic activity of pulmonary vein cardiomyocytes

Speaker: Doctor L. Pannell (Bristol, GB)

Access the full session

Basic science 1

Speakers: Doctor J. Yang, Doctor M. Ruppert, Doctor G. Caluori, Doctor S. Angendohr, Doctor A. Carpenter...

Access

About the event

EHRA 2024

7 April - 9 April 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources